切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2014, Vol. 03 ›› Issue (05) : 307 -311. doi: 10.3877/cma.j.issn.2095-3232.2014.05.012

所属专题: 文献

基础研究

荧光成像技术活体示踪裸鼠肝细胞癌肺转移
叶志强1, 刘旭辉1, 吴飞龙1, 赵坤2, 潘卫东2,()   
  1. 1. 510630 广州,中山大学附属第三医院急诊科
    2. 510630 广州,中山大学附属第三医院肝胆外科
  • 收稿日期:2014-06-17 出版日期:2014-10-10
  • 通信作者: 潘卫东
  • 基金资助:
    国家自然科学基金(81172783)

Tracking pulmonary metastasis of hepatocellular carcinoma of nude mouse in vivo using fluorescence imaging

Zhiqiang Ye1, Xuhui Liu1, Feilong Wu1, Kun Zhao2, Weidong Pan2,()   

  1. 1. Emergency Department, the Third Afflicted Hospital of Sun Yat-sen University, Guangzhou 510630, China
  • Received:2014-06-17 Published:2014-10-10
  • Corresponding author: Weidong Pan
  • About author:
    Corresponding author: Pan Weidong, Email:
引用本文:

叶志强, 刘旭辉, 吴飞龙, 赵坤, 潘卫东. 荧光成像技术活体示踪裸鼠肝细胞癌肺转移[J]. 中华肝脏外科手术学电子杂志, 2014, 03(05): 307-311.

Zhiqiang Ye, Xuhui Liu, Feilong Wu, Kun Zhao, Weidong Pan. Tracking pulmonary metastasis of hepatocellular carcinoma of nude mouse in vivo using fluorescence imaging[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2014, 03(05): 307-311.

目的

探讨荧光素酶标记肝细胞癌(肝癌)细胞的荧光成像技术在活体示踪裸鼠肝癌肺转移中的价值。

方法

应用低转移潜能HCC97L、高转移潜能HCC97H肝癌细胞建立稳定表达荧光素酶的肝癌细胞株HCC97L-FL、HCC97H-FL。24只裸鼠按随机数字表法随机分为HCC97L-FL组和HCC97H-FL组。分别将5×106个HCC97L-FL和HCC97H-FL细胞加入磷酸盐缓冲液(PBS)50 μl,制成细胞悬液。将细胞悬液注入裸鼠尾静脉,建立荧光素示踪的裸鼠肝癌肺转移模型。观察荧光成像示踪肺转移瘤大体标本及组织标本情况。两组数据比较采用t检验。

结果

荧光检测发现,HCC97L-FL、HCC97H-FL细胞均可发出强烈荧光。建模后2~3周,HCC97H-FL组裸鼠的肺部收集到荧光信号,3~4周荧光强度逐渐增强;HCC97L-FL组裸鼠无可见的肺部荧光信号。建模后4周HCC97H-FL组荧光强度为(1.73 ± 0.16)×104 a.u.,明显高于HCC97L-FL组的(0.03 ±0.01)×104 a.u.(t=23.652, P<0.05)。建模后4周HCC97H-FL组裸鼠肺脏密布大小不等转移瘤病灶,部分较大病灶突出于肺脏表面;HCC97L-FL组中未观察到转移瘤。转移瘤癌细胞核异型性明显,具备肝癌特征。

结论

荧光素酶标记肝癌细胞的荧光成像技术可对裸鼠肝癌肺转移进行活体、动态示踪。该技术为体内肝癌细胞生长、侵袭、转移的研究提供了可靠的量化研究手段。

Objective

To investigate the value of fluorescence imaging of labeling the hepatocellular carcinoma (HCC) cells with luciferase in tracking the pulmonary metastasis of HCC of nude mouse in vivo.

Methods

Low metastatic potential HCC97L and high metastatic potential HCC97H cells were transfected into HCC cell lines HCC97L-FL, HCC97H-FL with stable expression of luciferase. A total of 24 nude mice were randomly divided into HCC97L-FL group and HCC97H-FL group by the random number table method. Cell suspension was prepared by adding HCC97L-FL, HCC97H-FL cells (5×106) into the phosphate buffered saline (PBS, 50 μl) respectively. Cell suspension was injected into the caudal vein of nude mice. The model of tracking pulmonary metastasis of HCC with fluorescein was established. The gross and tissue samples of the pulmonary metastasis tracked by fluorescence imaging were observed. The data between two groups were compared using t test.

Results

Through fluorescence detection, intensive fluorescence could be observed in the HCC97L-FL, HCC97H-FL cells. After 2 to 3 weeks of modeling, fluorescence signal was collected from the nude mice lung in HCC97L-FL group. The fluorescence intensity enhanced gradually in 3-4 week. No fluorescence signal was observed in the nude mice lung in HCC97H-FL group. After 4 weeks of modeling, the fluorescence intensity was (1.73 ± 0.16) ×104 a.u. in HCC97H-FL group, which was significantly higher than that in HCC97L-FL group [(0.03 ±0.01) ×104 a.u.] (t=23.652, P<0.05). The nude mice lung in HCC97H-FL group was densely covered with metastatic tumors of varying sizes after 4 weeks of modeling. Some of the bigger tumors were visible on the lung surface. No metastatic tumor was observed in the HCC97L-FL group. The metastatic tumor was observed with an obvious cell nuclear atypia and characteristic feature of HCC.

Conclusions

Fluorescence imaging of using luciferase to label HCC cells can dynamically track the pulmonary metastasis of HCC of nude mouse . This technique provides a reliable quantitative research method for studying the growth, invasion and metastasis of HCC cells in vivo.

图1 活体荧光成像系统检测四种细胞荧光效果
图2 建模后四周活体荧光成像系统检测HCC97L-FL、HCC97H-FL组裸鼠荧光
图3 活体荧光成像系统检测HCC97L-FL、HCC97H-FL组裸鼠荧光强度的变化
图4 HCC97L-FL、HCC97H-FL组裸鼠肺转移瘤大体标本及组织切片
[1]
吴孟超.肝癌在中国[J/CD].中华肝脏外科手术学电子杂志,2012, 1(1):3-4.
[2]
Ye X, Guo Y, Zhang Q, et al. βKlotho suppresses tumor growth in hepatocellular carcinoma by regulating Akt/GSK-3β/cyclin D1 signaling pathway[J]. PLoS One, 2013, 8(1):e55615.
[3]
黄泽萍,王平,郑荣琴,等.常规超声检查与超声造影对肝脏局灶性病变检出能力的比较[J/CD].中华肝脏外科手术学电子杂志,2013, 2(4):29-33.
[4]
Scaggiante B, Kazemi M, Pozzato G, et al. Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials[J]. World J Gastroenterol, 2014, 20(5):1268-1288.
[5]
Zhang Q, Du Y, Xue Z, et al. Comprehensive evaluation of the anti-angiogenic and anti-neoplastic effects of Endostar on liver cancer through optical molecular imaging[J]. PLoS One, 2014, 9(1):e85559.
[6]
Zheng SG, Xu HX, Liu LN. Management of hepatocellular carcinoma: the role of contrast-enhanced ultrasound[J]. World J Radiol, 2014, 6(1):7-14.
[7]
Guo Y, Chen W, Wang W, et al. Simultaneous diagnosis and gene therapy of immuno-rejection in rat allogeneic heart transplantation model using a T-cell-targeted theranostic nanosystem[J]. ACS Nano, 2012, 6(12):10646-10657.
[8]
Page AJ, Cosgrove DC, Philosophe B, et al. Hepatocellular carcinoma: diagnosis, management, and prognosis[J]. Surg Oncol Clin N Am, 2014, 23(2):289-311.
[9]
Higgins MC, Soulen MC. Combining locoregional therapies in the treatment of hepatocellular carcinoma[J]. Semin Intervent Radiol, 2013, 30(1):74-81.
[10]
Lencioni R, Petruzzi P, Crocetti L. Chemoembolization of hepatocellular carcinoma[J]. Semin Intervent Radiol, 2013, 30(1):3-11.
[11]
Vitale A, Volk M, Cillo U. Transplant benefit for patients with hepatocellular carcinoma[J]. World J Gastroenterol, 2013, 19(48):9183-9188.
[12]
Liu Y, Zhao YM, Akers W, et al. First in-human intraoperative imaging of HCC using the fluorescence goggle system and transarterial delivery of near-infrared fluorescent imaging agent: a pilot study[J]. Transl Res, 203, 162(5):324-331.
[13]
Shen YC, Lin ZZ, Hsu CH, et al. Clinical trials in hepatocellular carcinoma: an update[J]. Liver Cancer, 2013, 2(3/4):345-364.
[14]
Chao JA, Yoon YJ, Singer RH. Imaging translation in single cells using fluorescent microscopy[J]. Cold Spring Harb Perspect Biol, 2012, 4(11):a012310.
[15]
游敏玲,罗满芳,廖蔚茜,等.柴芪益肝颗粒联合紫杉醇抑制裸鼠肝癌生长的在体成像研究[J].南方医科大学学报,2012, 32(7):1042-1045.
[16]
Gohar AV, Cao R, Jenkins P, et al. Subcellular localization-dependent changes in EGFP fluorescence lifetime measured by time-resolved flow cytometry[J].Biomed Opt Express, 2013, 4(8):1390-1400.
[17]
Close D, Xu T, Smartt A, et al. The evolution of the bacterial luciferase gene cassette (lux) as a real-time bioreporter[J]. Sensors, 2012, 12(1):732-752.
[1] 晏晴艳, 雍晓梅, 罗洪, 杜敏. 成都地区老年转移性乳腺癌的预后及生存因素研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 636-638.
[2] 王兴, 张峰伟. 腹腔镜肝切除联合断面射频消融治疗伴微血管侵犯肝细胞癌的临床研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 580-583.
[3] 康海, 谭武宾, 周松, 毛正, 米泽振, 李铁求. 膀胱癌根治术后阴茎转移一例报告[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(05): 523-525.
[4] 杜锡林, 谭凯, 贺小军, 白亮亮, 赵瑶瑶. 肝细胞癌转化治疗方式[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 597-601.
[5] 魏小勇. 原发性肝癌转化治疗焦点问题探讨[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 602-607.
[6] 张其坤, 商福超, 李琪, 栗光明, 王孟龙. 联合脾切除对肝癌合并门静脉高压症患者根治性切除术后的生存获益分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 613-618.
[7] 严庆, 刘颖, 邓斐文, 陈焕伟. 微血管侵犯对肝癌肝移植患者生存预后的影响[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 624-629.
[8] 张文华, 陶焠, 胡添松. 不同部位外生型肝癌临床病理特点及其对术后肝内复发和预后影响[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 651-655.
[9] 韩宇, 张武, 李安琪, 陈文颖, 谢斯栋. MRI肝脏影像报告和数据系统对非肝硬化乙肝患者肝细胞癌的诊断价值[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 669-673.
[10] 张维志, 刘连新. 基于生物信息学分析IPO7在肝癌中的表达及意义[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 694-701.
[11] 陈安, 冯娟, 杨振宇, 杜锡林, 柏强善, 阴继凯, 臧莉, 鲁建国. 基于生物信息学分析CCN4在肝细胞癌中表达及其临床意义[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 702-707.
[12] 叶文涛, 吴忠均, 廖锐. 癌旁组织ALOX15表达与肝癌根治性切除术后预后的关系[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 708-712.
[13] 吴晨瑞, 廖锐, 贺强, 潘龙, 黄平, 曹洪祥, 赵益, 王永琛, 黄俊杰, 孙睿锐. MDT模式下肝动脉灌注化疗联合免疫靶向治疗肝细胞癌多处转移一例[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 713-716.
[14] 王峰杰, 王礼光, 廖珊, 刘颖, 符荣党, 陈焕伟. 腹腔镜右半肝切除术治疗肝癌的安全性与疗效[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 517-522.
[15] 张海涛, 贾哲, 马超, 张其坤, 武聚山, 郭庆良, 曾道炳, 栗光明, 王孟龙. 手术切除与射频消融治疗血管周围型单发小肝癌临床疗效分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 523-527.
阅读次数
全文


摘要